MELOXICAM

MELOXICAM was reported 58673 times

MELOXICAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 64 0.7356
1 GRIP STRENGTH 127 0.5546
2 SWOLLEN JOINT COUNT 82 0.3280
3 C-REACTIVE PROTEIN 251 0.2708
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 493 0.2461
5 VITAL CAPACITY DECREASED 101 0.2254
6 LUPUS VULGARIS 284 0.2254
7 REVERSIBLE AIRWAYS OBSTRUCTION 103 0.2028
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 110 0.1647
9 X-RAY ABNORMAL 284 0.1587
10 SWOLLEN JOINT COUNT INCREASED 495 0.1551
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 289 0.1393
12 TENOSYNOVITIS STENOSANS 77 0.1382
13 RHEUMATIC FEVER 562 0.1260
14 SPUTUM CULTURE POSITIVE 102 0.1256
15 PORPHYRIA ACUTE 169 0.1178
16 DISLOCATION OF VERTEBRA 267 0.1170
17 RETINITIS 189 0.1093
18 ALLERGY TO CHEMICALS 134 0.1075
19 FACET JOINT SYNDROME 320 0.0982
20 RHEUMATOID FACTOR POSITIVE 558 0.0965
21 C-REACTIVE PROTEIN ABNORMAL 613 0.0955
22 REBOUND ACID HYPERSECRETION 267 0.0882
23 DUODENAL ULCER PERFORATION 651 0.0875
24 BRONCHIAL SECRETION RETENTION 105 0.0824
25 TENOSYNOVITIS 227 0.0822
26 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 576 0.0803
27 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 81 0.0763
28 PERIPHERAL VENOUS DISEASE 310 0.0758
29 SERONEGATIVE ARTHRITIS 81 0.0707
30 BONE EROSION 248 0.0701
31 RHEUMATOID LUNG 66 0.0691
32 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 443 0.0681
33 SYNOVIAL CYST 302 0.0653
34 BLOOD FOLATE DECREASED 47 0.0646
35 MUSCLE INJURY 521 0.0628
36 RHEUMATOID NODULE 171 0.0620
37 HYPERPARATHYROIDISM SECONDARY 153 0.0610
38 HELICOBACTER INFECTION 623 0.0606
39 HAND DEFORMITY 790 0.0602
40 NEPHROGENIC ANAEMIA 276 0.0595
41 DRUG TOLERANCE DECREASED 166 0.0591
42 CREPITATIONS 170 0.0570
43 AUTOIMMUNE DISORDER 540 0.0553
44 MYOFASCIAL PAIN SYNDROME 39 0.0549
45 FOLLICULITIS 572 0.0545
46 BURSITIS 643 0.0529
47 JOINT RANGE OF MOTION DECREASED 689 0.0513
48 LIP DRY 459 0.0505
49 GRIP STRENGTH DECREASED 428 0.0486
50 BREAST CANCER STAGE III 308 0.0475
51 SCLERITIS 76 0.0474
52 SCIATICA 714 0.0447
53 FIBROMYALGIA 1065 0.0438
54 PEMPHIGUS 545 0.0435
55 SYNOVITIS 783 0.0434
56 ENTHESOPATHY 67 0.0428
57 DACTYLITIS 38 0.0387
58 EXOSTOSIS 345 0.0377
59 LIVE BIRTH 311 0.0371
60 SACROILIITIS 68 0.0360
61 WOUND INFECTION 393 0.0359
62 PERICARDITIS 564 0.0335
63 PSORIATIC ARTHROPATHY 1308 0.0322
64 MATERNAL EXPOSURE TIMING UNSPECIFIED 121 0.0322
65 LOWER LIMB FRACTURE 608 0.0316
66 FOOT DEFORMITY 346 0.0312
67 CHRONIC KIDNEY DISEASE 2340 0.0308
68 PLEURITIC PAIN 85 0.0308
69 ANKYLOSING SPONDYLITIS 404 0.0306
70 ANTINUCLEAR ANTIBODY POSITIVE 98 0.0301
71 BLOOD PRESSURE DIASTOLIC ABNORMAL 76 0.0299
72 IRRITABLE BOWEL SYNDROME 623 0.0290
73 WALKING AID USER 189 0.0286
74 GLOSSODYNIA 624 0.0278
75 JOINT DESTRUCTION 43 0.0276
76 LINEAR IGA DISEASE 46 0.0276
77 HYPERCHOLESTEROLAEMIA 265 0.0274
78 HIP ARTHROPLASTY 404 0.0264
79 END STAGE RENAL DISEASE 478 0.0262
80 CUSHINGOID 83 0.0258
81 OSTEOARTHRITIS 1096 0.0258
82 PULMONARY TOXICITY 181 0.0256
83 LIVER INJURY 611 0.0249
84 RED BLOOD CELL SEDIMENTATION RATE INCREASED 274 0.0247
85 LIPOMA 63 0.0243
86 WOUND 670 0.0239
87 KNEE ARTHROPLASTY 502 0.0238
88 OBESITY 378 0.0237
89 JOINT EFFUSION 163 0.0236
90 INTERVERTEBRAL DISC DEGENERATION 218 0.0235
91 ULCER HAEMORRHAGE 159 0.0235
92 PRE-EXISTING CONDITION IMPROVED 146 0.0234
93 MULTIPLE ALLERGIES 182 0.0232
94 ARTHROPATHY 1278 0.0230
95 LUPUS-LIKE SYNDROME 208 0.0229
96 CONTRAINDICATED PRODUCT ADMINISTERED 661 0.0218
97 SPONDYLITIS 78 0.0214
98 SYSTEMIC LUPUS ERYTHEMATOSUS 739 0.0208
99 ESSENTIAL HYPERTENSION 38 0.0207
100 TYPE 2 DIABETES MELLITUS 698 0.0207
101 RHEUMATOID ARTHRITIS 2346 0.0206
102 PULMONARY FIBROSIS 392 0.0204
103 PRESCRIBED OVERDOSE 393 0.0203
104 UPPER-AIRWAY COUGH SYNDROME 167 0.0202
105 BLOOD PRESSURE SYSTOLIC ABNORMAL 50 0.0202
106 IMPAIRED HEALING 659 0.0201
107 CARTILAGE INJURY 49 0.0198
108 VIRAL UPPER RESPIRATORY TRACT INFECTION 94 0.0198
109 BLOOD CHOLESTEROL INCREASED 909 0.0195
110 EYE INJURY 59 0.0194
111 JOINT DISLOCATION 205 0.0194
112 LUMBAR SPINAL STENOSIS 56 0.0191
113 RADICULOPATHY 50 0.0190
114 MUSCULOSKELETAL STIFFNESS 1660 0.0189
115 MUSCULOSKELETAL PAIN 992 0.0189
116 NIGHT SWEATS 604 0.0187
117 PEPTIC ULCER 62 0.0187
118 SPINAL FUSION SURGERY 73 0.0180
119 IMPAIRED GASTRIC EMPTYING 245 0.0180
120 ROAD TRAFFIC ACCIDENT 746 0.0178
121 JOINT SWELLING 2147 0.0178
122 SPINAL OSTEOARTHRITIS 155 0.0176
123 MENOPAUSAL SYMPTOMS 41 0.0176
124 MOBILITY DECREASED 1252 0.0174
125 GAIT INABILITY 576 0.0172
126 MENISCUS INJURY 105 0.0171
127 THERAPEUTIC PRODUCT EFFECT DECREASED 763 0.0170
128 NERVE COMPRESSION 156 0.0169
129 TRIGGER FINGER 69 0.0169
130 BREAST CANCER STAGE II 140 0.0168
131 NECK SURGERY 39 0.0167
132 RENAL INJURY 497 0.0167
133 SPINAL STENOSIS 69 0.0167
134 LOWER RESPIRATORY TRACT INFECTION 750 0.0165
135 DISCOMFORT 999 0.0164
136 JOINT STIFFNESS 425 0.0162
137 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 764 0.0159
138 CARPAL TUNNEL SYNDROME 222 0.0158
139 TENDERNESS 165 0.0158
140 LIVER DISORDER 702 0.0158
141 ARTHRITIS 1232 0.0156
142 PULMONARY MASS 233 0.0156
143 BLEPHAROSPASM 98 0.0155
144 DEFORMITY 145 0.0155
145 BLISTER 868 0.0154
146 INFUSION SITE REACTION 46 0.0154
147 TUBULOINTERSTITIAL NEPHRITIS 288 0.0154
148 OSTEOPOROSIS 630 0.0153
149 PRODUCT ADMINISTRATION INTERRUPTED 119 0.0151
150 EAR INFECTION 399 0.0150
151 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 249 0.0146
152 FINGER DEFORMITY 71 0.0146
153 PLANTAR FASCIITIS 49 0.0146
154 DRUG INTOLERANCE 1382 0.0143
155 SINUSITIS 1452 0.0142
156 WEIGHT FLUCTUATION 148 0.0141
157 TENDON INJURY 52 0.0140
158 EOSINOPHIL COUNT INCREASED 116 0.0139
159 LUNG DISORDER 678 0.0138
160 INTERVERTEBRAL DISC PROTRUSION 302 0.0138
161 WHEEZING 817 0.0138
162 PRESCRIBED UNDERDOSE 273 0.0137
163 FLANK PAIN 128 0.0136
164 NODULE 177 0.0135
165 OEDEMA 734 0.0135
166 INFLAMMATION 698 0.0135
167 EAR PAIN 262 0.0135
168 SLEEP APNOEA SYNDROME 256 0.0134
169 SPINAL COLUMN STENOSIS 63 0.0133
170 ROTATOR CUFF SYNDROME 171 0.0133
171 INFUSION RELATED REACTION 881 0.0133
172 NAIL DISORDER 116 0.0132
173 TENDON DISORDER 86 0.0132
174 DELIRIUM 451 0.0130
175 INTERVERTEBRAL DISC DISORDER 55 0.0129
176 OBSTRUCTIVE AIRWAYS DISORDER 142 0.0128
177 UPPER RESPIRATORY TRACT INFECTION 589 0.0127
178 PREGNANCY 255 0.0127
179 PERIPHERAL SWELLING 1960 0.0127
180 OSTEOPENIA 193 0.0127
181 MUSCULOSKELETAL DISCOMFORT 218 0.0127
182 ONYCHOMADESIS 53 0.0126
183 HEPATIC ENZYME INCREASED 858 0.0126
184 STOMATITIS 763 0.0126
185 HEPATIC CIRRHOSIS 236 0.0125
186 C-REACTIVE PROTEIN INCREASED 456 0.0125
187 INFLAMMATORY MARKER INCREASED 62 0.0125
188 SPINAL DISORDER 118 0.0124
189 SHOULDER OPERATION 53 0.0124
190 ECONOMIC PROBLEM 185 0.0122
191 DEMYELINATION 50 0.0122
192 DUODENAL ULCER 86 0.0122
193 DRY MOUTH 981 0.0121
194 SEASONAL ALLERGY 171 0.0121
195 SENSITIVITY TO WEATHER CHANGE 63 0.0120
196 PUSTULAR PSORIASIS 41 0.0119
197 SWELLING 1112 0.0119
198 DECREASED INTEREST 70 0.0119
199 ATELECTASIS 114 0.0118
200 THERAPY NON-RESPONDER 528 0.0117
201 SLEEP DISORDER 828 0.0117
202 VITAMIN D DEFICIENCY 113 0.0116
203 BACK DISORDER 188 0.0116
204 LISTLESS 38 0.0115
205 PARANASAL SINUS HYPERSECRETION 44 0.0115
206 ANHEDONIA 301 0.0114
207 RESPIRATORY TRACT INFECTION 298 0.0114
208 ULCER 182 0.0114
209 NECK PAIN 639 0.0114
210 LIMB OPERATION 54 0.0112
211 ARTHRITIS INFECTIVE 52 0.0112
212 GASTRIC ULCER 212 0.0111
213 INJURY 783 0.0111
214 LIGAMENT SPRAIN 110 0.0111
215 FOOT FRACTURE 210 0.0111
216 CONTUSION 1061 0.0110
217 CERVICAL VERTEBRAL FRACTURE 38 0.0110
218 RENAL FAILURE 1454 0.0109
219 ONYCHOMYCOSIS 48 0.0109
220 TREATMENT FAILURE 906 0.0109
221 POST-TRAUMATIC STRESS DISORDER 73 0.0109
222 LIGAMENT RUPTURE 48 0.0109
223 POLYARTHRITIS 57 0.0108
224 BONE DENSITY DECREASED 337 0.0107
225 URINE ODOUR ABNORMAL 63 0.0107
226 FULL BLOOD COUNT ABNORMAL 113 0.0107
227 DRUG TOLERANCE 54 0.0107
228 GASTROOESOPHAGEAL REFLUX DISEASE 859 0.0107
229 ARTHRALGIA 4413 0.0106
230 ANKLE FRACTURE 164 0.0106
231 RED CELL DISTRIBUTION WIDTH INCREASED 44 0.0106
232 SNORING 40 0.0106
233 ACUTE KIDNEY INJURY 1619 0.0106
234 BACK INJURY 115 0.0106
235 MUSCLE STRAIN 91 0.0105
236 FOOT OPERATION 52 0.0105
237 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 180 0.0105
238 SPINAL OPERATION 129 0.0105
239 KNEE OPERATION 103 0.0105
240 PROSTATOMEGALY 41 0.0104
241 SPINAL PAIN 119 0.0101
242 DIVERTICULUM 72 0.0101
243 ARTHROPOD BITE 75 0.0101
244 HYPOAESTHESIA 1514 0.0101
245 ILL-DEFINED DISORDER 612 0.0101
246 VITAMIN D DECREASED 86 0.0101
247 PHOTOPHOBIA 189 0.0100
248 VAGINAL INFECTION 47 0.0100
249 NEPHROPATHY 93 0.0100
250 INFECTION 1439 0.0099
251 RASH PRURITIC 537 0.0099
252 RESPIRATORY DISORDER 296 0.0099
253 HIATUS HERNIA 127 0.0098
254 GOITRE 40 0.0098
255 DRY EYE 480 0.0096
256 GASTROINTESTINAL DISORDER 850 0.0095
257 BLOOD PRESSURE SYSTOLIC INCREASED 185 0.0095
258 HAND FRACTURE 67 0.0094
259 HYPERKERATOSIS 52 0.0094
260 URINARY TRACT DISORDER 42 0.0093
261 QUALITY OF LIFE DECREASED 125 0.0093
262 SKIN ABRASION 44 0.0093
263 ABDOMINAL DISCOMFORT 1557 0.0093
264 MUSCULAR WEAKNESS 1054 0.0093
265 TOOTH INFECTION 122 0.0092
266 FREQUENT BOWEL MOVEMENTS 248 0.0092
267 ASTHMA 1037 0.0092
268 LUMBAR VERTEBRAL FRACTURE 42 0.0092
269 SOMNAMBULISM 60 0.0091
270 GAIT DISTURBANCE 1748 0.0091
271 JOINT INJURY 195 0.0091
272 HUMERUS FRACTURE 44 0.0091
273 PAIN IN EXTREMITY 2683 0.0091
274 HIP SURGERY 49 0.0090
275 SCOLIOSIS 56 0.0090
276 PSYCHOLOGICAL TRAUMA 78 0.0090
277 HAEMOGLOBIN INCREASED 41 0.0090
278 HAIR DISORDER 74 0.0090
279 IMPAIRED QUALITY OF LIFE 129 0.0090
280 NASOPHARYNGITIS 1648 0.0089
281 TOOTH ABSCESS 91 0.0089
282 BLOOD PRESSURE FLUCTUATION 214 0.0089
283 WHITE BLOOD CELL COUNT INCREASED 342 0.0089
284 IMPAIRED WORK ABILITY 190 0.0089
285 INCREASED TENDENCY TO BRUISE 81 0.0088
286 BONE DISORDER 160 0.0088
287 SUSPECTED SUICIDE 41 0.0087
288 LIMB INJURY 236 0.0087
289 DIABETIC NEUROPATHY 43 0.0087
290 DYSSTASIA 253 0.0087
291 CEREBRAL DISORDER 64 0.0086
292 AUTOIMMUNE HEPATITIS 60 0.0086
293 POSTOPERATIVE WOUND INFECTION 58 0.0086
294 BACK PAIN 1992 0.0086
295 RHINITIS ALLERGIC 38 0.0085
296 EYE PAIN 481 0.0085
297 BRONCHITIS 631 0.0085
298 RASH MACULO-PAPULAR 189 0.0085
299 HYPERTRANSAMINASAEMIA 59 0.0085
300 DISABILITY 167 0.0084
301 LABORATORY TEST ABNORMAL 248 0.0084
302 NEPHROLITHIASIS 385 0.0084
303 NEURALGIA 204 0.0084
304 IMMUNODEFICIENCY 125 0.0084
305 APHTHOUS ULCER 65 0.0084
306 FEELING OF BODY TEMPERATURE CHANGE 49 0.0084
307 PELVIC FRACTURE 65 0.0083
308 MIGRAINE 796 0.0083
309 SINUS CONGESTION 112 0.0083
310 AMNESIA 539 0.0083
311 TOOTH FRACTURE 91 0.0082
312 MEMORY IMPAIRMENT 1130 0.0082
313 HAIR COLOUR CHANGES 101 0.0081
314 INFUSION SITE SWELLING 51 0.0081
315 CONCOMITANT DISEASE AGGRAVATED 50 0.0081
316 RECTAL HAEMORRHAGE 348 0.0081
317 PSORIASIS 1053 0.0081
318 SKIN ULCER 208 0.0080
319 DYSPEPSIA 791 0.0080
320 GASTROINTESTINAL MOTILITY DISORDER 43 0.0080
321 HYPERTENSION 1690 0.0080
322 PAIN 4886 0.0079
323 BODY HEIGHT DECREASED 85 0.0079
324 GASTRIC ULCER HAEMORRHAGE 44 0.0079
325 MAJOR DEPRESSION 58 0.0079
326 PLEURISY 47 0.0079
327 GASTRIC HAEMORRHAGE 91 0.0079
328 STREPTOCOCCAL INFECTION 44 0.0079
329 POST PROCEDURAL INFECTION 64 0.0079
330 CONJUNCTIVITIS 146 0.0079
331 BODY TEMPERATURE DECREASED 77 0.0078
332 OVERWEIGHT 42 0.0078
333 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 555 0.0078
334 CYSTITIS 248 0.0078
335 FEELING JITTERY 148 0.0078
336 INFUSION SITE PAIN 100 0.0078
337 TENDON RUPTURE 95 0.0077
338 SINUS DISORDER 152 0.0077
339 STRESS FRACTURE 41 0.0076
340 MADAROSIS 88 0.0076
341 SINUS HEADACHE 45 0.0076
342 PERIPHERAL VASCULAR DISORDER 39 0.0076
343 INTENTIONAL PRODUCT USE ISSUE 660 0.0075
344 FEELING HOT 461 0.0075
345 ALOPECIA 1475 0.0075
346 MUSCULOSKELETAL CHEST PAIN 116 0.0075
347 ABDOMINAL PAIN UPPER 1535 0.0074
348 DEPRESSION 1689 0.0074
349 DECREASED ACTIVITY 80 0.0074
350 DERMATITIS CONTACT 84 0.0074
351 CONCUSSION 57 0.0074
352 TENDONITIS 113 0.0073
353 TASTE DISORDER 148 0.0073
354 PAROSMIA 55 0.0073
355 MICTURITION URGENCY 83 0.0073
356 MUSCLE SPASMS 1331 0.0072
357 AFFECTIVE DISORDER 57 0.0072
358 MULTIPLE FRACTURES 119 0.0072
359 PRODUCT DOSE OMISSION IN ERROR 205 0.0072
360 HEAD DISCOMFORT 128 0.0072
361 LIVER FUNCTION TEST INCREASED 155 0.0072
362 ORAL CANDIDIASIS 95 0.0072
363 LOCALISED INFECTION 174 0.0072
364 CONDITION AGGRAVATED 2186 0.0072
365 CATARACT 428 0.0072
366 UPPER LIMB FRACTURE 143 0.0072
367 RENAL TUBULAR NECROSIS 70 0.0071
368 INJECTION SITE VESICLES 43 0.0071
369 RESTLESS LEGS SYNDROME 129 0.0071
370 ORAL DISORDER 52 0.0071
371 LYMPHOEDEMA 49 0.0071
372 ORAL HERPES 138 0.0071
373 RHINITIS 57 0.0071
374 IRON DEFICIENCY ANAEMIA 65 0.0070
375 CYST 87 0.0070
376 HYPERSENSITIVITY 1300 0.0070
377 SKIN LACERATION 76 0.0070
378 GENERAL PHYSICAL HEALTH DETERIORATION 808 0.0070
379 PARAESTHESIA 1094 0.0069
380 HYSTERECTOMY 60 0.0069
381 EAR DISCOMFORT 71 0.0069
382 CHEST PAIN 1281 0.0069
383 OROPHARYNGEAL PAIN 639 0.0069
384 CONFUSIONAL STATE 1112 0.0069
385 HAIR TEXTURE ABNORMAL 92 0.0069
386 SKIN WARM 40 0.0069
387 SURGERY 403 0.0069
388 ANXIETY 1956 0.0069
389 PERONEAL NERVE PALSY 39 0.0069
390 DERMATITIS ALLERGIC 86 0.0068
391 VISUAL IMPAIRMENT 847 0.0068
392 INSURANCE ISSUE 104 0.0068
393 LIMB DISCOMFORT 209 0.0067
394 NERVE INJURY 74 0.0066
395 LARGE INTESTINE POLYP 46 0.0066
396 PERIPHERAL COLDNESS 91 0.0066
397 HERNIA 128 0.0066
398 MATERNAL EXPOSURE DURING PREGNANCY 590 0.0066
399 RIB FRACTURE 136 0.0066
400 HOT FLUSH 498 0.0066
401 TENDON PAIN 50 0.0066
402 INTENTIONAL DOSE OMISSION 188 0.0066
403 ADRENAL INSUFFICIENCY 80 0.0066
404 RED BLOOD CELL COUNT DECREASED 188 0.0066
405 NASAL CONGESTION 385 0.0065
406 POOR QUALITY SLEEP 141 0.0065
407 WEIGHT INCREASED 1466 0.0065
408 BEDRIDDEN 86 0.0065
409 GASTRITIS 172 0.0065
410 KIDNEY INFECTION 128 0.0065
411 UVEITIS 88 0.0065
412 THERAPEUTIC RESPONSE DECREASED 391 0.0064
413 BIPOLAR DISORDER 70 0.0064
414 DIVERTICULITIS 178 0.0064
415 INFUSION SITE ERYTHEMA 54 0.0064
416 DECREASED APPETITE 1487 0.0064
417 GROIN PAIN 56 0.0064
418 GASTROENTERITIS VIRAL 115 0.0064
419 PHARYNGITIS 79 0.0064
420 LOCAL SWELLING 110 0.0063
421 CHOLECYSTITIS CHRONIC 42 0.0063
422 URINARY TRACT INFECTION 1070 0.0063
423 POLYP 41 0.0063
424 WRIST FRACTURE 75 0.0063
425 GLUCOSE TOLERANCE IMPAIRED 37 0.0063
426 BREAST MASS 42 0.0062
427 OSTEOMYELITIS 113 0.0062
428 DENTAL CARIES 69 0.0062
429 INITIAL INSOMNIA 64 0.0062
430 AFFECT LABILITY 60 0.0062
431 FATIGUE 4833 0.0062
432 MUSCULOSKELETAL DISORDER 118 0.0062
433 PRODUCT LABEL ISSUE 42 0.0062
434 FURUNCLE 49 0.0062
435 INSOMNIA 1642 0.0062
436 IMMUNE SYSTEM DISORDER 81 0.0061
437 BLOOD PRESSURE INCREASED 938 0.0061
438 CELLULITIS 308 0.0061
439 ONYCHOCLASIS 42 0.0061
440 OEDEMA PERIPHERAL 743 0.0061
441 POOR VENOUS ACCESS 63 0.0061
442 SCAR 104 0.0061
443 COMPLETED SUICIDE 506 0.0061
444 CONGENITAL ANOMALY 47 0.0061
445 INFLUENZA 677 0.0061
446 INJECTION SITE IRRITATION 77 0.0060
447 VIRAL INFECTION 201 0.0060
448 APPETITE DISORDER 40 0.0060
449 ORAL PAIN 135 0.0060
450 DRUG-INDUCED LIVER INJURY 189 0.0060
451 MYOSITIS 54 0.0060
452 WEIGHT DECREASED 1679 0.0060
453 HEPATIC STEATOSIS 112 0.0060
454 SPUTUM DISCOLOURED 57 0.0060
455 PAIN IN JAW 170 0.0060
456 PHOTOSENSITIVITY REACTION 99 0.0060
457 HYPOKINESIA 87 0.0060
458 RESPIRATORY TRACT CONGESTION 95 0.0060
459 BALANCE DISORDER 515 0.0060
460 MALAISE 2612 0.0059
461 PRODUCTIVE COUGH 284 0.0059
462 HEAD INJURY 188 0.0059
463 THERAPEUTIC RESPONSE SHORTENED 196 0.0059
464 URTICARIA 984 0.0059
465 FALL 1954 0.0059
466 EMPHYSEMA 59 0.0058
467 LACERATION 55 0.0058
468 EYE INFECTION 66 0.0058
469 SNEEZING 131 0.0058
470 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
471 PROSTATIC SPECIFIC ANTIGEN INCREASED 80 0.0058
472 HAEMORRHOIDS 113 0.0058
473 MUSCLE SPASTICITY 71 0.0058
474 HERPES ZOSTER 332 0.0058
475 PANCREATITIS 305 0.0058
476 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 301 0.0058
477 RENAL PAIN 61 0.0057
478 PNEUMONIA 1863 0.0057
479 UTERINE LEIOMYOMA 42 0.0057
480 PRURITUS 2207 0.0057
481 DRUG EFFECT INCOMPLETE 208 0.0057
482 INJECTION SITE NODULE 63 0.0057
483 EYE IRRITATION 329 0.0057
484 FACIAL PAIN 51 0.0057
485 GLAUCOMA 110 0.0057
486 OCULAR DISCOMFORT 64 0.0057
487 COLITIS ULCERATIVE 254 0.0057
488 BLOOD COUNT ABNORMAL 86 0.0057
489 TOOTH DISORDER 126 0.0057
490 PYELONEPHRITIS 49 0.0056
491 RHINORRHOEA 365 0.0056
492 ASTHENIA 2121 0.0056
493 GOUT 101 0.0056
494 HEADACHE 3527 0.0056
495 DIZZINESS 2784 0.0056
496 TOOTHACHE 101 0.0056
497 THERAPEUTIC RESPONSE UNEXPECTED 250 0.0056
498 COUGH 1556 0.0055
499 HYPERSOMNIA 159 0.0055
500 BURNING SENSATION 388 0.0055
501 PRODUCT DOSE OMISSION 361 0.0055
502 GINGIVAL PAIN 44 0.0055
503 SCAB 63 0.0055
504 APHONIA 77 0.0055
505 COELIAC DISEASE 54 0.0055
506 URINARY INCONTINENCE 163 0.0055
507 SCRATCH 58 0.0055
508 GASTROINTESTINAL HAEMORRHAGE 458 0.0055
509 BLOOD URINE PRESENT 104 0.0055
510 MYALGIA 931 0.0055
511 DIZZINESS POSTURAL 53 0.0055
512 PHARYNGITIS STREPTOCOCCAL 59 0.0054
513 VERTIGO 332 0.0054
514 ACCIDENT 65 0.0054
515 SKIN INFECTION 61 0.0054
516 STAPHYLOCOCCAL INFECTION 179 0.0054
517 GASTRIC DISORDER 186 0.0054
518 ARTERIOSCLEROSIS 51 0.0054
519 RENAL CYST 43 0.0054
520 MOUTH ULCERATION 114 0.0054
521 CHROMATURIA 122 0.0054
522 BLOOD IRON DECREASED 64 0.0054
523 INCONTINENCE 57 0.0054
524 BLOOD PRESSURE ABNORMAL 107 0.0054
525 THERAPY CESSATION 276 0.0054
526 HYPOAESTHESIA ORAL 81 0.0054
527 RASH 2341 0.0054
528 ACTIVITIES OF DAILY LIVING IMPAIRED 106 0.0053
529 FUNGAL INFECTION 178 0.0053
530 PARAESTHESIA ORAL 77 0.0053
531 BLADDER DISORDER 53 0.0053
532 SOMNOLENCE 1072 0.0053
533 BASAL CELL CARCINOMA 83 0.0053
534 DIARRHOEA 3424 0.0053
535 TOOTH EXTRACTION 66 0.0053
536 SKIN SWELLING 46 0.0053
537 SKIN HAEMORRHAGE 78 0.0053
538 LIP SWELLING 175 0.0052
539 POLLAKIURIA 219 0.0052
540 FEELING ABNORMAL 1257 0.0052
541 BOWEL MOVEMENT IRREGULARITY 40 0.0052
542 SKIN FISSURES 102 0.0052
543 IMMUNOSUPPRESSION 46 0.0052
544 CANDIDA INFECTION 88 0.0052
545 OROPHARYNGEAL DISCOMFORT 47 0.0052
546 MYOCLONUS 62 0.0052
547 EYE DISCHARGE 54 0.0052
548 INJECTION SITE BRUISING 414 0.0052
549 FEAR OF INJECTION 37 0.0052
550 SKIN DISCOLOURATION 238 0.0052
551 CHOLECYSTECTOMY 59 0.0052
552 POST PROCEDURAL COMPLICATION 99 0.0052
553 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 40 0.0051
554 FLUSHING 523 0.0051
555 PRESYNCOPE 125 0.0051
556 SPINAL FRACTURE 103 0.0051
557 TINNITUS 236 0.0051
558 CONSTIPATION 1120 0.0051
559 OESOPHAGITIS 56 0.0051
560 MUSCLE TIGHTNESS 83 0.0051
561 NEUROPATHY PERIPHERAL 487 0.0051
562 HEART RATE INCREASED 507 0.0051
563 NOCTURIA 62 0.0051
564 INJECTION SITE EXTRAVASATION 63 0.0051
565 HYPERLIPIDAEMIA 61 0.0051
566 THINKING ABNORMAL 95 0.0051
567 BLOOD MAGNESIUM DECREASED 44 0.0051
568 NAUSEA 4028 0.0051
569 MIDDLE INSOMNIA 95 0.0051
570 RASH PAPULAR 114 0.0051
571 ILLNESS 522 0.0051
572 VOMITING 2375 0.0050
573 INJECTION SITE PRURITUS 338 0.0050
574 BONE PAIN 295 0.0050
575 OCULAR HYPERAEMIA 239 0.0050
576 ABDOMINAL PAIN 1168 0.0050
577 DYSPNOEA 2829 0.0050
578 SWELLING FACE 325 0.0050
579 SENSORY DISTURBANCE 80 0.0050
580 SPINAL COMPRESSION FRACTURE 41 0.0050
581 ABSCESS 79 0.0049
582 URINARY RETENTION 165 0.0049
583 HIP FRACTURE 159 0.0049
584 DRUG EFFECT DECREASED 266 0.0049
585 DIPLOPIA 128 0.0049
586 HALLUCINATION 371 0.0049
587 BLOOD POTASSIUM DECREASED 148 0.0049
588 DYSURIA 181 0.0049
589 PHARYNGEAL SWELLING 48 0.0049
590 INTESTINAL PERFORATION 55 0.0049
591 HAEMATOCRIT DECREASED 97 0.0049
592 COVID-19 854 0.0049
593 PROCEDURAL PAIN 135 0.0049
594 MEDICATION ERROR 270 0.0049
595 MALIGNANT MELANOMA 65 0.0048
596 PRODUCT DISTRIBUTION ISSUE 45 0.0048
597 LOSS OF CONSCIOUSNESS 618 0.0048
598 CHOLELITHIASIS 158 0.0048
599 DYSPNOEA EXERTIONAL 181 0.0048
600 SLUGGISHNESS 49 0.0048
601 INFLAMMATORY BOWEL DISEASE 47 0.0048
602 GASTROINTESTINAL INFECTION 43 0.0048
603 PRODUCT USE ISSUE 899 0.0048
604 ANAL INCONTINENCE 43 0.0048
605 RENAL IMPAIRMENT 401 0.0048
606 ADVERSE DRUG REACTION 428 0.0048
607 FAECES DISCOLOURED 103 0.0047
608 ILEUS 59 0.0047
609 MOVEMENT DISORDER 152 0.0047
610 PRODUCT DOSE OMISSION ISSUE 1392 0.0047
611 LETHARGY 272 0.0047
612 BONE LOSS 71 0.0047
613 ATAXIA 56 0.0047
614 WHITE BLOOD CELL COUNT DECREASED 509 0.0047
615 DEPRESSED MOOD 248 0.0047
616 DRUG INEFFECTIVE 6182 0.0047
617 HYPERHIDROSIS 603 0.0047
618 OXYGEN SATURATION DECREASED 263 0.0047
619 VITREOUS FLOATERS 46 0.0047
620 SKIN DISORDER 156 0.0047
621 BLOOD CALCIUM INCREASED 41 0.0047
622 FLUID RETENTION 236 0.0046
623 ABNORMAL FAECES 38 0.0046
624 UPPER GASTROINTESTINAL HAEMORRHAGE 78 0.0046
625 CLOSTRIDIUM DIFFICILE INFECTION 101 0.0046
626 CRYING 168 0.0046
627 LACRIMATION INCREASED 139 0.0046
628 INJECTION SITE SWELLING 350 0.0046
629 EYE DISORDER 150 0.0046
630 INJECTION SITE DISCOLOURATION 57 0.0046
631 THERAPY INTERRUPTED 326 0.0046
632 RASH MACULAR 159 0.0045
633 SWOLLEN TONGUE 142 0.0045
634 SARS-COV-2 TEST POSITIVE 60 0.0045
635 VENTRICULAR EXTRASYSTOLES 47 0.0045
636 LYMPHADENOPATHY 160 0.0045
637 PYREXIA 1562 0.0045
638 BODY TEMPERATURE INCREASED 92 0.0045
639 SINUS TACHYCARDIA 64 0.0045
640 SKIN LESION 123 0.0045
641 TREMOR 743 0.0045
642 INJECTION SITE WARMTH 92 0.0045
643 HEART RATE DECREASED 157 0.0045
644 ORAL DISCOMFORT 62 0.0045
645 INTENTIONAL PRODUCT MISUSE 389 0.0044
646 MACULAR DEGENERATION 53 0.0044
647 FEEDING DISORDER 90 0.0044
648 FEELING COLD 123 0.0044
649 THROAT IRRITATION 198 0.0044
650 INFLUENZA LIKE ILLNESS 363 0.0044
651 BRAIN FOG 69 0.0044
652 NERVOUSNESS 230 0.0044
653 SECRETION DISCHARGE 55 0.0044
654 INJECTION SITE REACTION 301 0.0044
655 SQUAMOUS CELL CARCINOMA 41 0.0044
656 VISION BLURRED 598 0.0044
657 HEART RATE IRREGULAR 98 0.0043
658 IMPAIRED DRIVING ABILITY 49 0.0043
659 RASH ERYTHEMATOUS 206 0.0043
660 COGNITIVE DISORDER 201 0.0043
661 BLOOD SODIUM DECREASED 81 0.0043
662 INJECTION SITE ERYTHEMA 533 0.0043
663 MASS 60 0.0043
664 RESTLESSNESS 157 0.0043
665 ANAPHYLACTIC REACTION 237 0.0043
666 FLATULENCE 243 0.0043
667 FRACTURE 81 0.0043
668 DIABETES MELLITUS 326 0.0043
669 ABNORMAL DREAMS 118 0.0043
670 INJECTION SITE RASH 131 0.0043
671 COLD SWEAT 75 0.0043
672 HUNGER 59 0.0042
673 MOOD SWINGS 135 0.0042
674 ABDOMINAL DISTENSION 441 0.0042
675 EXPOSURE DURING PREGNANCY 260 0.0042
676 MELAENA 92 0.0042
677 CHEST DISCOMFORT 428 0.0042
678 SUPRAVENTRICULAR TACHYCARDIA 40 0.0042
679 DYSPHONIA 244 0.0042
680 INJECTION SITE PAIN 1278 0.0042
681 CARDIOMEGALY 51 0.0041
682 SMALL INTESTINAL OBSTRUCTION 51 0.0041
683 HAEMOGLOBIN DECREASED 425 0.0041
684 INJECTION SITE HAEMATOMA 60 0.0041
685 SKIN CANCER 89 0.0041
686 EATING DISORDER 88 0.0041
687 ADVERSE EVENT 380 0.0041
688 VASCULITIS 48 0.0041
689 GENERALISED TONIC-CLONIC SEIZURE 68 0.0041
690 ACUTE RESPIRATORY FAILURE 79 0.0041
691 GALLBLADDER DISORDER 73 0.0041
692 EMOTIONAL DISTRESS 494 0.0041
693 PRURITUS GENERALISED 88 0.0041
694 FEMUR FRACTURE 126 0.0041
695 ATRIAL FIBRILLATION 396 0.0041
696 DYSKINESIA 165 0.0041
697 AGEUSIA 101 0.0040
698 DRY THROAT 41 0.0040
699 DEHYDRATION 537 0.0040
700 HYPOACUSIS 173 0.0040
701 CORONARY ARTERY OCCLUSION 55 0.0040
702 HYPOKALAEMIA 185 0.0040
703 ABASIA 99 0.0040
704 TRANSIENT ISCHAEMIC ATTACK 135 0.0040
705 UNRESPONSIVE TO STIMULI 103 0.0040
706 RETCHING 85 0.0040
707 DRUG EFFECT LESS THAN EXPECTED 59 0.0040
708 APATHY 58 0.0040
709 THIRST 71 0.0040
710 NIGHTMARE 137 0.0040
711 INJECTION SITE URTICARIA 97 0.0039
712 HOSPICE CARE 39 0.0039
713 MUSCLE TWITCHING 91 0.0039
714 MULTIPLE SCLEROSIS RELAPSE 270 0.0039
715 MALNUTRITION 44 0.0039
716 ERUCTATION 76 0.0039
717 LUNG INFECTION 61 0.0039
718 EPILEPSY 120 0.0039
719 FULL BLOOD COUNT DECREASED 79 0.0039
720 SKIN EXFOLIATION 330 0.0039
721 PRODUCT USE IN UNAPPROVED INDICATION 967 0.0039
722 CHILLS 457 0.0039
723 PARANOIA 67 0.0039
724 UNEVALUABLE EVENT 294 0.0039
725 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 700 0.0039
726 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 213 0.0039
727 GINGIVAL BLEEDING 53 0.0039
728 EYE INFLAMMATION 37 0.0039
729 PALPITATIONS 454 0.0039
730 INJECTION SITE HAEMORRHAGE 309 0.0039
731 DELUSION 60 0.0039
732 PRODUCT ADMINISTRATION ERROR 78 0.0039
733 INTERNAL HAEMORRHAGE 44 0.0038
734 CHOKING 75 0.0038
735 THYROID DISORDER 59 0.0038
736 DRUG DOSE OMISSION 632 0.0038
737 LIVER FUNCTION TEST ABNORMAL 111 0.0038
738 PELVIC PAIN 69 0.0038
739 METABOLIC ACIDOSIS 121 0.0038
740 TEMPERATURE INTOLERANCE 39 0.0038
741 BACTERIAL INFECTION 70 0.0037
742 SEROTONIN SYNDROME 72 0.0037
743 MULTIPLE SCLEROSIS 179 0.0037
744 PULMONARY CONGESTION 49 0.0037
745 WRONG TECHNIQUE IN DRUG USAGE PROCESS 135 0.0037
746 EYE SWELLING 138 0.0037
747 PHARYNGEAL OEDEMA 57 0.0037
748 HYPOTHYROIDISM 118 0.0037
749 DISTURBANCE IN ATTENTION 198 0.0037
750 GLOMERULAR FILTRATION RATE DECREASED 45 0.0037
751 DERMATITIS ATOPIC 192 0.0036
752 GASTROINTESTINAL PAIN 40 0.0036
753 DEAFNESS 95 0.0036
754 INJECTION SITE INDURATION 47 0.0036
755 APHASIA 109 0.0036
756 INJECTION SITE MASS 133 0.0036
757 INTERSTITIAL LUNG DISEASE 174 0.0036
758 THROAT TIGHTNESS 97 0.0036
759 DYSGEUSIA 264 0.0035
760 MUSCLE ATROPHY 45 0.0035
761 DRUG INTERACTION 563 0.0035
762 ADVERSE REACTION 47 0.0035
763 EYE PRURITUS 119 0.0035
764 DEEP VEIN THROMBOSIS 230 0.0035
765 CHOLECYSTITIS 42 0.0035
766 BLOOD UREA INCREASED 59 0.0035
767 DYSPHAGIA 333 0.0035
768 MENTAL IMPAIRMENT 85 0.0035
769 ORTHOSTATIC HYPOTENSION 61 0.0035
770 PULMONARY THROMBOSIS 38 0.0035
771 HYPOPHAGIA 89 0.0035
772 COAGULOPATHY 58 0.0035
773 COVID-19 PNEUMONIA 41 0.0035
774 ERYTHEMA 713 0.0035
775 THROMBOSIS 279 0.0035
776 CORONARY ARTERY DISEASE 105 0.0035
777 UNDERDOSE 253 0.0035
778 SUICIDAL IDEATION 317 0.0035
779 IRRITABILITY 208 0.0035
780 PANIC ATTACK 126 0.0035
781 BLOOD POTASSIUM INCREASED 56 0.0034
782 HYPOMAGNESAEMIA 48 0.0034
783 LYMPHOMA 53 0.0034
784 DYSARTHRIA 129 0.0034
785 MENTAL DISORDER 149 0.0034
786 HALLUCINATION, VISUAL 72 0.0034
787 BLOOD CALCIUM DECREASED 38 0.0034
788 INTESTINAL OBSTRUCTION 127 0.0034
789 CARDIO-RESPIRATORY ARREST 140 0.0033
790 DERMATITIS 70 0.0033
791 ACUTE MYOCARDIAL INFARCTION 98 0.0033
792 HAEMATOMA 86 0.0033
793 OSTEONECROSIS 109 0.0033
794 RENAL DISORDER 154 0.0033
795 DEVICE MALFUNCTION 232 0.0033
796 PLATELET COUNT INCREASED 43 0.0033
797 LYMPHOCYTE COUNT DECREASED 58 0.0033
798 TOOTH LOSS 68 0.0033
799 MENTAL STATUS CHANGES 91 0.0033
800 FEAR 88 0.0033
801 RESPIRATORY ARREST 90 0.0033
802 POST PROCEDURAL HAEMORRHAGE 38 0.0033
803 TACHYCARDIA 289 0.0032
804 EPISTAXIS 243 0.0032
805 SPEECH DISORDER 170 0.0032
806 PERICARDIAL EFFUSION 75 0.0032
807 ABDOMINAL PAIN LOWER 82 0.0032
808 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 230 0.0032
809 HAEMATOCHEZIA 178 0.0032
810 DISORIENTATION 126 0.0032
811 GLYCOSYLATED HAEMOGLOBIN INCREASED 80 0.0032
812 DEPRESSED LEVEL OF CONSCIOUSNESS 125 0.0032
813 HAEMOPTYSIS 88 0.0032
814 SEPSIS 351 0.0031
815 OFF LABEL USE 2751 0.0031
816 BLOOD TRIGLYCERIDES INCREASED 55 0.0031
817 DISEASE RECURRENCE 148 0.0031
818 PRODUCT PHYSICAL ISSUE 62 0.0031
819 NEOPLASM MALIGNANT 205 0.0031
820 BLOOD PRESSURE DECREASED 204 0.0031
821 BLOOD TEST ABNORMAL 43 0.0031
822 COLITIS 116 0.0031
823 NEEDLE ISSUE 89 0.0031
824 DRY SKIN 408 0.0031
825 WITHDRAWAL SYNDROME 128 0.0030
826 PULMONARY EMBOLISM 289 0.0030
827 PRODUCT SUBSTITUTION ISSUE 175 0.0030
828 LEUKOPENIA 152 0.0030
829 HYPONATRAEMIA 171 0.0030
830 GASTROENTERITIS 44 0.0030
831 CARDIOGENIC SHOCK 43 0.0030
832 EMOTIONAL DISORDER 92 0.0030
833 LEUKOCYTOSIS 54 0.0030
834 SYNCOPE 298 0.0030
835 TREATMENT NONCOMPLIANCE 162 0.0030
836 ANGER 100 0.0030
837 CARDIAC FAILURE CONGESTIVE 236 0.0029
838 ANGINA PECTORIS 84 0.0029
839 INCREASED APPETITE 56 0.0029
840 HYPOTENSION 587 0.0029
841 RENAL FAILURE ACUTE 124 0.0029
842 MANIA 48 0.0029
843 DEVICE ISSUE 260 0.0029
844 BREAST CANCER 270 0.0029
845 ECZEMA 151 0.0029
846 BLOOD GLUCOSE ABNORMAL 53 0.0029
847 DEMENTIA 80 0.0029
848 AGITATION 210 0.0029
849 PRODUCT USE COMPLAINT 45 0.0029
850 PRODUCT AVAILABILITY ISSUE 65 0.0029
851 HEPATITIS 73 0.0029
852 PNEUMOTHORAX 45 0.0028
853 BLINDNESS UNILATERAL 40 0.0028
854 OSTEONECROSIS OF JAW 70 0.0028
855 RASH GENERALISED 73 0.0028
856 PRODUCT QUALITY ISSUE 382 0.0028
857 PSYCHOTIC DISORDER 83 0.0028
858 BRONCHOSPASM 40 0.0028
859 HAEMORRHAGE 292 0.0028
860 MOOD ALTERED 76 0.0028
861 ANAEMIA 530 0.0028
862 BLOOD ALKALINE PHOSPHATASE INCREASED 69 0.0028
863 INCORRECT DOSE ADMINISTERED 633 0.0028
864 PULMONARY OEDEMA 124 0.0028
865 SEDATION 72 0.0027
866 TOXICITY TO VARIOUS AGENTS 461 0.0027
867 ALANINE AMINOTRANSFERASE INCREASED 167 0.0027
868 COMA 129 0.0027
869 ANOSMIA 39 0.0027
870 EXPIRED PRODUCT ADMINISTERED 89 0.0027
871 HOSPITALISATION 408 0.0027
872 HEPATOTOXICITY 59 0.0026
873 BLOOD CREATININE INCREASED 173 0.0026
874 ARRHYTHMIA 125 0.0026
875 APPLICATION SITE PAIN 58 0.0026
876 ANGIOEDEMA 116 0.0026
877 STEVENS-JOHNSON SYNDROME 58 0.0026
878 HEMIPARESIS 44 0.0026
879 CARDIAC DISORDER 243 0.0026
880 HYPOCALCAEMIA 49 0.0026
881 CARDIOMYOPATHY 38 0.0026
882 TOXIC EPIDERMAL NECROLYSIS 39 0.0026
883 CARDIAC ARREST 212 0.0026
884 HYPERKALAEMIA 90 0.0026
885 PAIN OF SKIN 69 0.0026
886 ASPARTATE AMINOTRANSFERASE INCREASED 135 0.0025
887 DEVICE RELATED INFECTION 39 0.0025
888 SEIZURE 290 0.0025
889 COLON CANCER 37 0.0025
890 BREAST CANCER FEMALE 66 0.0025
891 RESPIRATORY FAILURE 179 0.0025
892 HAEMATEMESIS 62 0.0024
893 CARDIOVASCULAR DISORDER 62 0.0024
894 PRODUCT DISPENSING ERROR 53 0.0024
895 EXPOSURE VIA SKIN CONTACT 63 0.0024
896 DIABETIC KETOACIDOSIS 58 0.0024
897 ENCEPHALOPATHY 59 0.0024
898 BRADYCARDIA 127 0.0024
899 PALLOR 65 0.0024
900 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
901 HALLUCINATION, AUDITORY 37 0.0023
902 LACTIC ACIDOSIS 75 0.0023
903 INTENTIONAL DRUG MISUSE 48 0.0023
904 BLINDNESS 93 0.0023
905 PNEUMONIA ASPIRATION 57 0.0023
906 PLATELET COUNT DECREASED 243 0.0023
907 HYPOGLYCAEMIA 110 0.0023
908 PRODUCT PRESCRIBING ERROR 54 0.0023
909 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 455 0.0022
910 ABNORMAL BEHAVIOUR 88 0.0022
911 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
912 PROTEINURIA 42 0.0022
913 BLOOD GLUCOSE DECREASED 106 0.0022
914 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
915 DRUG ERUPTION 39 0.0022
916 CEREBROVASCULAR ACCIDENT 372 0.0022
917 HYPOXIA 77 0.0022
918 APPLICATION SITE ERYTHEMA 57 0.0022
919 INCORRECT DRUG ADMINISTRATION DURATION 61 0.0022
920 HAEMATURIA 74 0.0022
921 BLOOD GLUCOSE INCREASED 407 0.0022
922 THROMBOCYTOPENIA 239 0.0021
923 PULMONARY HYPERTENSION 44 0.0021
924 PNEUMONITIS 57 0.0021
925 PLEURAL EFFUSION 127 0.0021
926 APPLICATION SITE PRURITUS 47 0.0021
927 JAUNDICE 55 0.0020
928 VAGINAL HAEMORRHAGE 88 0.0020
929 NERVOUS SYSTEM DISORDER 63 0.0020
930 PRODUCT ADHESION ISSUE 72 0.0020
931 INTENTIONAL OVERDOSE 129 0.0020
932 ACNE 149 0.0020
933 MYOCARDIAL INFARCTION 341 0.0020
934 HYPERGLYCAEMIA 71 0.0019
935 ACCIDENTAL EXPOSURE TO PRODUCT 195 0.0019
936 SUICIDE ATTEMPT 114 0.0019
937 LUNG NEOPLASM MALIGNANT 77 0.0019
938 MUCOSAL INFLAMMATION 49 0.0019
939 PANCREATITIS ACUTE 42 0.0019
940 OVERDOSE 403 0.0019
941 DRUG ADMINISTRATION ERROR 57 0.0019
942 GASTRIC CANCER 47 0.0019
943 TRANSAMINASES INCREASED 41 0.0018
944 PRODUCT PRESCRIBING ISSUE 40 0.0018
945 ACCIDENTAL OVERDOSE 67 0.0018
946 RHABDOMYOLYSIS 76 0.0018
947 DRUG WITHDRAWAL SYNDROME 159 0.0018
948 EXTRA DOSE ADMINISTERED 73 0.0018
949 ERECTILE DYSFUNCTION 46 0.0018
950 SKIN IRRITATION 81 0.0018
951 NEOPLASM PROGRESSION 61 0.0018
952 CARDIAC FAILURE 138 0.0017
953 ASCITES 49 0.0017
954 VISUAL ACUITY REDUCED 55 0.0017
955 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
956 DISEASE PROGRESSION 194 0.0016
957 SEPTIC SHOCK 71 0.0016
958 DEVICE DELIVERY SYSTEM ISSUE 44 0.0016
959 AGGRESSION 80 0.0016
960 NEUTROPHIL COUNT DECREASED 65 0.0016
961 BLOOD BILIRUBIN INCREASED 43 0.0016
962 CONVULSION 91 0.0016
963 EXTRAPYRAMIDAL DISORDER 39 0.0016
964 DEVICE LEAKAGE 68 0.0016
965 CEREBRAL INFARCTION 38 0.0016
966 CEREBRAL HAEMORRHAGE 54 0.0015
967 PLASMA CELL MYELOMA 58 0.0015
968 SKIN BURNING SENSATION 105 0.0015
969 HEPATIC FAILURE 44 0.0015
970 DEVICE DISLOCATION 62 0.0014
971 DRUG ABUSE 117 0.0014
972 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
973 PANCREATIC CARCINOMA 40 0.0014
974 TARDIVE DYSKINESIA 39 0.0014
975 PANCYTOPENIA 75 0.0013
976 NO ADVERSE EVENT 234 0.0013
977 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
978 DEVICE BREAKAGE 51 0.0013
979 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 42 0.0012
980 DEATH 1037 0.0012
981 DRUG DEPENDENCE 191 0.0012
982 NEUTROPENIA 159 0.0012
983 INCORRECT ROUTE OF DRUG ADMINISTRATION 40 0.0011
984 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 52 0.0011
985 PRODUCT STORAGE ERROR 95 0.0011
986 MALIGNANT NEOPLASM PROGRESSION 102 0.0010
987 FEBRILE NEUTROPENIA 64 0.0010
988 PROSTATE CANCER 67 0.0008
989 DEVICE DIFFICULT TO USE 48 0.0007
990 DRUG DOSE OMISSION BY DEVICE 56 0.0007